Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Assets (2020 - 2025)

Agilon Health's Other Non-Current Assets history spans 6 years, with the latest figure at $83.5 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 44.78% year-over-year to $83.5 million; the TTM value through Dec 2025 reached $83.5 million, down 44.78%, while the annual FY2025 figure was $83.5 million, 44.78% down from the prior year.
  • Other Non-Current Assets reached $83.5 million in Q4 2025 per AGL's latest filing, down from $132.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $161.7 million in Q1 2025 to a low of $39.5 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $123.1 million, with a median of $126.7 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: tumbled 65.01% in 2022, then soared 267.65% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $113.0 million in 2021, then crashed by 65.01% to $39.5 million in 2022, then skyrocketed by 267.65% to $145.3 million in 2023, then increased by 4.01% to $151.1 million in 2024, then tumbled by 44.78% to $83.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Other Non-Current Assets are $83.5 million (Q4 2025), $132.7 million (Q3 2025), and $143.1 million (Q2 2025).